Table 6.
Published local control and survival rate of early GC treated with 6 MV definite radiotherapy
| Author (year) | Patient number | Local Control (%) | OS (%) | CSS (%) |
|---|---|---|---|---|
| [ref] |
|
5 year*, 10 year # |
5 year *, 10 year# |
5 year*, 10 year# |
| Warde et al. [5] |
T1 + T2: 72 |
T1a: 91* |
T1 + T2: 75.8* |
NA |
| |
|
T1b: 82* |
|
|
| |
|
T2: 69* |
|
|
| Lee et al. [18] |
T1: 86 |
T1a: 82.2* |
T1: 85* |
NA |
| |
T2: 29 |
T1b: 76.2* |
T2: 74* |
|
| |
|
T2: 68.1* |
|
|
| Franchin et al. [23] |
T1: 323 |
T1: 90# |
T1: 66# |
NA |
| |
T2: 87 |
T2: 78# |
T2: 55# |
|
| Cellai & Frata et al. [6,7] |
T1: 35 |
T1: 84*, 83# |
T1: 77*, 57# |
T1: 95*, 93# |
| |
T2: 68 |
T2: 73*, 70# |
T2: 59*, 37# |
T2: 89*, 86# |
| Chera et al. [8] |
T1 + T2: 23 |
T1a: 94*, 93# |
T1 a: 82*, 62# |
T1a: 97*, 97# |
| |
|
T1b: 93*, 91# |
T1b: 83*, 57# |
T1b: 99*, 95# |
| |
|
T2a: 80*, 80# |
T2a: 76*, 51# |
T2a: 94*, 93# |
| |
|
T2b: 70*, 67# |
T2b: 78*, 49# |
T2b: 90*, 84# |
| Current series |
T1: 433 |
T1a: 92*, 91# |
T1: 89*, 74# |
T1: 98*, 97# |
| |
|
T1b: 89*, 87# |
T2: 89*, 70# |
T2: 98*, 97# |
| T2: 262 | T2: 79*, 77# |
Abbreviations: yr = year; NA = not available; OS = overall survival; CSS = cause specific survival.